Serum Adenosine Deaminase in patients with Type-2 Diabetes Mellitus and its Relation with Blood Glucose and Glycated Haemoglobin levels
DOI:
https://doi.org/10.7439/ijbr.v5i9.771Abstract
Background: Diabetes mellitus is a metabolic characterized bydeficiency of insulin and insulin resistance. Adenosine deaminase (ADA) modulates the bioactivity of insulin and Adenosine receptorsstimulate glucogenolysis and gluconeogenesis.but its role in Type 2 diabetes mellitus is not yet characterized. Aim and Objectives : The present study aimed to evaluate the serum Adenosine Deaminase level and to correlate ADA levels with Blood Glucose and Glycated hemoglobin levels in Type-2 Diabetes Mellitus patients. Material and Method: The study population of 120 patients were divided into 3 groups: Group A which consisted of 40 normal healthy individuals without any complication or history of Diabetes. Group B included 40 patients of Type 2 Diabetes Mellitus both with HbA1c 7%. Group C consisted of 40 patients of Type 2 Diabetes Mellitus with HbA1c >7% (n=40). Fasting blood sugar, HbA1c, ADA, and body mass Index were estimated in all the subjects under study. Results: The study showed that mean Fasting Blood Sugar, Post prandial Blood sugar and HbA1c concentration was significantly higher in Group C and Group B compared to Group A. Compared with the well-controlled Type-2 Diabetes Mellitus patients (HbA1c 7%), the poorly controlled group (HbA1c > 7%) showed significantly increased ADA activity (49.79 18.12 U/L vs. 90.10 32.75; P 0.001). The correlation between Adenosine Deaminase and HbA1c was positive and significant in both Group B (r= 0. 389; p= 0.007) and Group C (r = 0.430; p 0.001). Conclusion: Serum ADA levels may have an important role in determining the glycemic status in Diabetics. A positive correlation between ADA level with glycemic control suggest its important role in glucose and lipid metabolic derangements seen in Type 2 Diabetes Mellitus patients.Downloads
Download data is not yet available.
Downloads
Published
2014-09-30
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.
How to Cite
1.
Serum Adenosine Deaminase in patients with Type-2 Diabetes Mellitus and its Relation with Blood Glucose and Glycated Haemoglobin levels. Int Jour of Biomed Res [Internet]. 2014 Sep. 30 [cited 2024 Oct. 18];5(9):556-8. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/1069